Longevity Medicine
What Is Precision Medicine? Personalized Healthcare Explained
Last reviewed: May 2026 · Haute MD Editorial Team
Precision medicine — also called personalized medicine or stratified medicine — is an approach to medical care that tailors prevention, diagnosis, and treatment to the individual patient's genetics, biomarkers, lifestyle, and environment rather than applying population-average guidelines to everyone. The traditional 'one-size-fits-all' medical model treats all patients with the same condition identically — precision medicine recognizes that two people with the same diagnosis may have fundamentally different biology requiring different treatment approaches. In oncology, precision medicine has transformed cancer treatment — molecularly targeted therapies based on tumor genetics produce dramatically better outcomes than chemotherapy in many cancers. In longevity and preventive medicine, precision medicine uses genomics, epigenomics, microbiomics, metabolomics, and advanced biomarker profiling to individualize prevention strategies.
How precision medicine works in practice
Genomics — genetic testing identifies disease risk variants (BRCA1/2 for breast/ovarian cancer, ApoE4 for Alzheimer's, Lp(a) genetics for cardiovascular risk, pharmacogenomics for drug metabolism), inherited conditions, and individual variation in drug response. Whole genome or whole exome sequencing provides the most comprehensive genetic picture. Biomarker profiling — comprehensive metabolomics, proteomics, and standard advanced clinical biomarkers create an individual metabolic fingerprint. A patient with elevated Lp(a), elevated ApoB, and borderline fasting insulin has a fundamentally different cardiovascular risk profile than another patient with 'normal' standard labs — precision medicine addresses the first patient's actual biology. Epigenomics — biological age and pace of aging measured through epigenetic clocks provide individualized aging metrics that guide intervention intensity. Microbiomics — individual gut microbiome composition influences nutrient metabolism, drug response, and systemic inflammation in ways that precision medicine incorporates into dietary and pharmacological recommendations.
Precision medicine in longevity medicine
In longevity medicine, precision medicine means — selecting cardiovascular prevention strategy based on actual lipid particle biology (ApoB, Lp(a), CAC score) rather than age-based guidelines; timing and intensity of hormone therapy based on individual sex hormone levels, SHBG, and symptoms rather than population averages; dietary recommendations based on individual glucose response (from CGM) rather than generic nutritional guidelines; cancer screening intensity based on genetic risk (BRCA testing, Lynch syndrome screening, ApoE4 status for neurological screening) rather than age-alone protocols; and supplement and pharmaceutical selection based on pharmacogenomic data (e.g., MTHFR variants affecting folate metabolism and homocysteine elevation — relevant to cognitive risk).
The technology enabling precision medicine
Next-generation sequencing (NGS) — has dramatically reduced the cost of genetic sequencing from $3 billion (Human Genome Project, 2003) to approximately $200-$500 for whole genome sequencing today. Multi-omics platforms — combining genomics, proteomics (SomaScan), metabolomics, microbiomics, and epigenomics provides a comprehensive biological picture; platforms like Function Health, Viome, and specialized longevity programs aggregate multi-omics data. Artificial intelligence — AI and machine learning are essential for making sense of the vast data generated by multi-omics profiling — identifying patterns, predicting risk, and personalizing recommendations from data volumes that exceed human analytical capacity. Clinical decision support — precision medicine platforms translate complex genetic and biomarker data into clinical recommendations physicians can act on.
Frequently Asked Questions
Is precision medicine available now or is it future medicine?
Precision medicine is available now in important domains — oncology (tumor genomics guiding cancer treatment), cardiology (Lp(a) testing, ApoB measurement, pharmacogenomics for statin dosing), and preventive longevity medicine (comprehensive biomarker profiling, epigenetic age testing, genetic risk assessment). It is not yet universally implemented in conventional primary care — accessing precision medicine approaches typically requires a longevity physician, concierge medicine program, or specialized preventive medicine practice.
What does a precision medicine evaluation involve?
A comprehensive precision medicine evaluation typically includes — whole genome or exome sequencing or targeted disease risk gene panel; comprehensive biomarker panel (advanced lipids, inflammatory markers, metabolic markers, hormones); epigenetic age testing (GrimAge, DunedinPACE); gut microbiome analysis; body composition (DEXA); cardiovascular imaging (CAC scoring, carotid IMT); and VO2 max testing. Total cost for a comprehensive multi-omics precision medicine evaluation — $3,000-$10,000 through specialized longevity programs; components can be obtained piecemeal at lower cost.
Is precision medicine covered by insurance?
Coverage varies by component. Genetic testing for established clinical indications (BRCA testing for cancer risk, pharmacogenomics, Lynch syndrome testing) is often covered. Advanced biomarkers (Lp(a), ApoB) are increasingly covered as cardiovascular risk assessment tools. Comprehensive longevity panels, epigenetic age testing, and multi-omics evaluations are generally not covered — they fall outside the reactive disease-treatment model that insurance reimbursement is designed around.
What is pharmacogenomics and how does it affect my medications?
Pharmacogenomics is the study of how an individual's genetic variants affect drug metabolism and response. Key examples — CYP2C19 variants affect clopidogrel (a blood thinner) metabolism, changing whether it is effective or needs dose adjustment; CYP2D6 variants affect metabolism of many antidepressants, opioids, and other drugs; SLCO1B1 variants affect statin transport and muscle side effect risk; MTHFR variants affect folate metabolism, homocysteine levels, and response to certain supplements. Pharmacogenomic testing can prevent adverse drug reactions, optimize drug selection, and guide dosing — available through specialized genetic testing companies and increasingly through primary care physicians.
Get Help Now
Speak with a Haute MD Longevity Medicine physician
Dr. George Kaltner
CEO
Longevity Medicine · Miami Beach, FL
View Profile
Dr. Alexander Golberg
Longevity Medicine · New York, NY
View Profile
Dr. Steven Victor
Regenerative Medicine Specialist
Longevity Medicine · New York, NY
View ProfileAre you a Longevity Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · LONGEVITY MEDICINE
What Is Longevity Medicine?
Longevity medicine uses evidence-based diagnostics and interventions to extend healthspan — the years lived in good health. Learn what it involves and who it's for.
Read GuideGuide · LONGEVITY MEDICINE
What Is Biological Age?
Biological age measures how old your cells and organs actually are — which may be years younger or older than your calendar age. Learn how it's measured and why it matters.
Read GuideGuide · LONGEVITY MEDICINE
What Is Executive Health Screening?
Executive health screening is a comprehensive one-day medical evaluation covering biomarkers, imaging, fitness testing, and cancer screening. Learn what's included and who it's for.
Read Guide